News

Merck stock could take another hit Thursday after the company reported another quarter of light sales for its HPV vaccine, ...
MSD is also bracing for a $200m hit due to tariffs as it accelerates US manufacturing and shifts its global supply strategy.
The company’s stock fell as much as 2.8% after markets opened in New York Thursday. For the first quarter, Merck’s results ...